摘要

This report describes real-world comparisons of survival, the average number of doses administered, the presence of postnaloxone signs and symptoms, and hospital transport refusal among people receiving 8-mg and 4-mg intranasal naloxone.

詳細內容

This report describes real-world comparisons of survival, the average number of doses administered, the presence of postnaloxone signs and symptoms, and hospital transport refusal among people receiving 8-mg and 4-mg intranasal naloxone.

關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---

萃取時間: 2026-02-05T15:10:12Z 資料來源: CDC MMWR